JT
KMTS

Jupiter Topco’s Kestra Medical Technologies KMTS Stock Holding History

Jupiter Topco’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
+11,300
New +$237K ﹤0.01% 2332

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jupiter Topco's KMTS Position: Q2 2026 in Review

Jupiter Topco opened a new position in Kestra Medical Technologies (KMTS) in Q2 2026: 11,300 shares worth $287K. The stake represents ﹤0.01% of the portfolio and ranks #2332 among its holdings.

102 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Jupiter Topco held 11,300 shares of Kestra Medical Technologies worth $287K as of Q2 2026.
  • Kestra Medical Technologies was a new Jupiter Topco position in Q2 2026.
  • Kestra Medical Technologies made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #2332 holding.
  • 102 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.